Dicerna Pharmaceuticals Inc Receivables Turnover Ratio (DRNA), from the third quarter 2021 to the third quarter 2020 current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Dicerna Pharmaceuticals Inc   (NASDAQ: DRNA)
 

Dicerna Pharmaceuticals Inc Accounts Receivables Turnover Ratio from the third quarter 2021 to the third quarter 2020

Quarterly Results, Trends, Rankings, Statistics


Dicerna Pharmaceuticals Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2021 to a ratio of 10.24, above the company average. This is a clear sign of healthy business climate in the Major Pharmaceutical Preparations industry and improving liquidity at their respective customers, during the third quarter 2021. Average receivable collection period, for the Dicerna Pharmaceuticals Inc in Sep 30 2021 quarter, has decreased to 36 days, compared to 38 days, in the Jun 30 2021 quarter.

If we take a look into Healthcare sector 388 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Sep 30 2021 from 2643 to 2845.

What is Receivable Turnover Ratio?
What is Dicerna Pharmaceuticals Inc Selling?


What is Receivable Turnover Ratio?




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

DRNA Receivables Turnover Ratio (Sep 30 2021)
III. Quarter		 (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter
Y / Y Receivable Change 23.83 % 26125 % 108.45 % -82.68 % 67.6 %
Y / Y Revenue Change 28.81 % 2.2 % 39.89 % 478.47 % 508.28 %
Receivable Turnover Ratio (TTM) 10.24 9.64 10.02 12 2.37
DRNA's Total Ranking # 2845 # 2643 # 2636 # 500 # 2634
Accounts Receivable average collection period days 36 38 36 30 154
Seq. Receivable Change 97.84 % -89.94 % -9.93 % 590.39 % 41800 %
Seq. Revenue Change 52.29 % -13.16 % 16.23 % -16.2 % 20.83 %


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 122
Healthcare Sector # 389
Overall Market # 2845

Receivable Turnover Ratio Statistics
High Average Low
0.26 0.1 0.01
(Sep 30 2021)   (Jun 30 2017)





DRNA Company Profile • Back to DRNA Efficiency Comparisons • Compare DRNA Receivables Turnover Ratio to its Competitors

Financial Statements
Dicerna Pharmaceuticals Inc 's Accounts Receivable $ 6 Millions Visit DRNA's Balance sheet
Dicerna Pharmaceuticals Inc 's Sales TTM $ 193 Millions Visit DRNA's Income Statement
Sources of DRNA's Revenues Visit DRNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
DRNA's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
DRNA's Growth Rates DRNA's Roa DRNA's Inventory Turnover Ratio DRNA's Dividend Comparisons
DRNA's Profitability Ratios DRNA's Roi DRNA's Asset Turnover Ratio DRNA's Dividend Growth
DRNA's Valuation Ratios DRNA's Roe DRNA's Financial Strength Ratios DRNA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Sep 30 2021, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Sep 30 2021 Receivable at quarter ending Sep 30 2021
Lifemd Inc   81.81 $ 78.352  Millions$ 0.958  Millions
Cytomx Therapeutics Inc   78.55 $ 66.219  Millions$ 0.843  Millions
Vystar Corporation  77.59 $ 30.264  Millions$ 0.390  Millions
Lifevantage Corp  72.28 $ 218.578  Millions$ 3.024  Millions
Inhibrx Biosciences Inc   62.87 $ 7.151  Millions$ 0.114  Millions
Eton Pharmaceuticals Inc   61.08 $ 15.820  Millions$ 0.259  Millions
Petvivo Holdings Inc   59.62 $ 0.015  Millions$ 0.000  Millions
Sonida Senior Living Inc   57.10 $ 257.319  Millions$ 4.506  Millions
Wearable Health Solutions, Inc.  56.79 $ 1.425  Millions$ 0.025  Millions
China Pharma Holdings Inc  51.27 $ 9.684  Millions$ 0.189  Millions
Merus N v   50.29 $ 43.414  Millions$ 0.863  Millions
Strata Critical Medical Inc   49.51 $ 67.785  Millions$ 1.369  Millions
Nature s Sunshine Products inc   47.02 $ 427.888  Millions$ 9.100  Millions
Agenus Inc  46.22 $ 306.668  Millions$ 6.635  Millions
Nurix Therapeutics Inc   45.79 $ 29.043  Millions$ 0.634  Millions
Brookdale Senior Living Inc   45.13 $ 3,011.489  Millions$ 66.735  Millions
Arrowhead Pharmaceuticals Inc   43.46 $ 138.287  Millions$ 3.182  Millions
Seres Therapeutics Inc   42.86 $ 155.270  Millions$ 3.623  Millions
Electromedical Technologies Inc   39.40 $ 0.851  Millions$ 0.022  Millions
Vtv Therapeutics Inc   38.22 $ 10.395  Millions$ 0.272  Millions
Celularity Inc   37.68 $ 27.402  Millions$ 0.727  Millions
Arvinas Inc   37.06 $ 26.684  Millions$ 0.720  Millions
National Vision Holdings Inc   37.00 $ 2,098.370  Millions$ 56.710  Millions
Fulcrum Therapeutics Inc   36.66 $ 18.330  Millions$ 0.500  Millions
Sqz Biotechnologies Company  36.44 $ 17.235  Millions$ 0.473  Millions
Sangui Biotech International Inc  33.55 $ 0.064  Millions$ 0.002  Millions
Albireo Pharma inc   32.97 $ 10.774  Millions$ 0.327  Millions
Advanced Container Technologies Inc   31.87 $ 4.790  Millions$ 0.150  Millions
Thorne Healthtech Inc   30.72 $ 48.010  Millions$ 1.563  Millions
Agape Atp Corporation  30.61 $ 1.322  Millions$ 0.043  Millions

Date modified: 2026-10-07T00:41:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.